Investigation of the mechanism of low-affinity anti-histone H1 monoclonal antibody that rescues mice from lethal endotoxin shock
Project/Area Number |
26861531
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Emergency medicine
|
Research Institution | Josai International University |
Principal Investigator |
Shimada Yayoi 城西国際大学, 大学共同利用機関等の部局等, 研究員 (70439024)
|
Project Period (FY) |
2014-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 抗-ヒストンH1抗体 / 抗-DNA抗体 / 多反応性抗体 / 抗体医薬 / 敗血症 |
Outline of Final Research Achievements |
Anti-histone H1 monoclonal antibody (mAb) C93-3 has a low-affinity for histone H1 and rescues mice from lethal endotoxin shock. The purposes of this study were to identify other antigens of C93-3 and investigate its mechanism. We found that C93-3 is polyreactive and binds to α-actinin 1, α-actinin 4, nucleolin, hnRNP U and DNA. Administration of commercial anti-DNA mAb to mice underwent endotoxin shock improved survival rate. This result suggests that C93-3 suppresses inflammation by capturing extracellular DNA. Therefore, capturing extracellular DNA may be a potential treatment against severe sepsis.
|
Report
(3 results)
Research Products
(7 results)
-
-
-
[Journal Article] A novel anti-histone H1 monoclonal antibody, SSV monoclonal antibody, improves lung injury and survival in a mouse model of lipopolysaccharide-induced sepsis-like syndrome2015
Author(s)
Toru Kusano, Kuei-Chen Chiang, Masafumi Inomata, Yayoi Shimada, Naoya Ohmori, Takeshi Goto, Shuji Sato, Shigeru Goto, Toshiaki Nakano, Seiji Kawamoto, Yuki Takaoka, Norio Shiraishi, Takayuki Noguchi, and Seigo Kitano
-
Journal Title
Biomed Research International
Volume: 2015
Pages: 491649-491649
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-